規制動向

The Korean Pharmaceutical Association announced it will mount legislative and policy resistance to the government's plan to expand prescription drug delivery to all telemedicine patients, refusing to join related government talks.

KFTC reports net fine refunds exceeding 106 bn KRW in seven months, highlighting a gap between its claimed 90% administrative‑lawsuit win rate and court rejections of fine calculations.

Lawmaker Kim Gyo‑heung called for a life‑cycle suicide‑prevention system and a National Suicide Prevention Fund, noting budget gaps. The Prime Minister agreed to examine the proposal closely.

Health professionals and the government in Korea call for formalizing multidisciplinary team care for hospitalized patients, including ward‑dedicated pharmacists, with staffing and compensation standards.

Korea Health Insurance Corp announced reduced premiums and additional coverage for lost dentures and disability aids for residents of newly declared special disaster zones.

The National Assembly Library announced a briefing on the UK’s Tobacco and Vapes Act 2026, aimed at preventing youth smoking and closing regulatory gaps for e‑cigarettes and nicotine pouches.

Civil society health groups in South Korea denounced the Lee Jae‑myung administration’s plan to fully expand telemedicine drug delivery, urging investment in public medical infrastructure instead.

HuBase co‑hosted a symposium in Seoul on May 23, offering practical criteria to assess pharmacy property values and contracts amid growing market complexity.

The EMA's Pharmacovigilance Risk Assessment Committee has started a review of injectable iron products concerning low blood phosphate levels and related bone problems.

The Korean government proposes broader prescription delivery for telemedicine patients, but experts question the evidence and note needed legal changes.

South Korea's MFDS fined TDS Farm 19.35 million KRW, replacing a 15‑day production halt for the Kataplasmaze formulation after finding missing concurrent manufacturing records.

Regulatory updates exempt pharmacies from business registration and provide a checklist, allowing pharmacy managers to act as product managers and outsource splitting without dedicated facilities.